Reviewed by RC Nelson, Health & Wellness Writer. Last updated May 2026.
Key Takeaways
- Compounded semaglutide as low as $130/mo, compounded tirzepatide as low as $199/mo
- One-price-per-medication regardless of dose, no subscription lock-in
- $50 off first month with code OAKNEW50
- US-licensed providers and state-licensed compounding pharmacies
- Async intake with no live video required, cash-pay only (no insurance billing)
- Newer brand with limited public track record
What Is Oak Weight Loss?
Oak is a telehealth weight-loss program offering compounded semaglutide and tirzepatide. The model is the same as the rest of the cash-pay compounded category: complete an online intake, get reviewed by a licensed provider, and have medication ship to your door from a compounding pharmacy.
Oak is newer than the established names in the space (Henry Meds, Hims, Eden), so the public footprint (Trustpilot reviews, press mentions, multi-year track record) is thinner. What you are getting is a standard async compounded program.
For a directory like ours, the question is: where does Oak fit in the comparison set? The honest answer is "in the middle of the budget-to-mid tier, similar to Henry Meds and Sprout Health, with a smaller public reputation."
Pricing Breakdown
Oak publishes a "one price, all dosages, no subscriptions" model with a single advertised rate per medication regardless of which dose strength you titrate to.
| Medication | Advertised Price |
|---|---|
| Compounded Semaglutide | As low as $130/mo |
| Compounded Tirzepatide | As low as $199/mo |
New patients can use code OAKNEW50 for $50 off the first month. The program is cash-pay, with no insurance billing and no publicly stated HSA/FSA eligibility.
For context against the rest of the field:
| Provider | Semaglutide From |
|---|---|
| GobyMeds | $99/mo |
| Oak | $130/mo |
| Henry Meds | $149/mo |
| Sprout Health | $149/mo |
| SHED | ~$175/mo |
| Yucca Health | $175 first / $275 ongoing |
Oak undercuts most established compounded providers on entry pricing. The trade-off is the public track record: Oak is newer than Henry Meds, Hims, or Eden, with fewer Trustpilot reviews and a thinner press footprint.
How It Works
- Online intake form. Standard medical history questionnaire covering weight, conditions, current medications, goals.
- Provider review. A US-licensed provider reviews your information async.
- Pharmacy fulfillment. If approved, medication is compounded by a state-licensed pharmacy.
- Shipping and ongoing support. Medication ships to your door. Provider support continues throughout the program.
The flow is the standard async compounded telehealth model. No video call, no scheduling, no waiting room.
Medications
Oak's program is built around two medications:
- Compounded Semaglutide: same active ingredient as Ozempic and Wegovy, prepared by a compounding pharmacy
- Compounded Tirzepatide: same active ingredient as Mounjaro and Zepbound
Brand-name FDA-approved options (Wegovy, Zepbound, Ozempic, Mounjaro) are not listed as part of the standard menu. The new oral GLP-1 pill Foundayo is also not part of Oak's program. For these, look at SHED, Eden, Ro, or PlushCare.
Pros
Competitive entry pricing. Compounded semaglutide as low as $130/mo and tirzepatide as low as $199/mo undercuts most established compounded providers on day one.
One-price-all-dosages. No surprise step-up when you titrate from 0.25mg to 1mg semaglutide or from 2.5mg to 7.5mg tirzepatide. The advertised monthly rate covers all dose strengths.
No subscription lock-in. Oak markets the program as a non-subscription model, so you can pause or stop without contract penalties.
$50 off first month. Code OAKNEW50 lowers the first-month entry cost on the published rates.
Standard async telehealth flow. No friction, no scheduling, no live calls. US-licensed providers and state-licensed compounding pharmacies.
Cons
Limited public track record. Newer brand without the multi-year Trustpilot history of Henry Meds, Hims, or Eden. If long-term reputation matters to you, the established names are a safer bet.
Compounded only. No branded Wegovy, Zepbound, Ozempic, or Mounjaro. No Foundayo oral pill. If clinical considerations push you toward FDA-approved options, Oak is not the right starting point.
No money-back guarantee. SHED's 10% body-weight guarantee and Yucca's onboarding-call commitment are real differentiators. Oak does not offer either.
State-availability not disclosed publicly. Confirm during intake if your state matters.
No insurance billing. Cash-pay only. HSA/FSA eligibility not stated.
Oak vs. The Competition
| Feature | Oak | Henry Meds | Sprout Health | SHED |
|---|---|---|---|---|
| Semaglutide from | $130/mo | $149/mo | $149/mo | ~$175/mo |
| Tirzepatide from | $199/mo | $249/mo | $199/mo | ~$245/mo |
| First-month promo | $50 off (OAKNEW50) | None | $200 off | Varies |
| LegitScript | Not stated | No | Yes | Yes |
| Money-back guarantee | No | No | No | 10% body weight |
| Branded options | No | No | Listed (retail) | Yes |
| Foundayo oral GLP-1 | No | No | No | Yes |
| Track record | 5,000+ members, 10,000+ patients | Established | 40K+ patients | 150K+ members |
| Insurance | No | No | No | No |
Who Is Oak Best For?
Oak makes sense for patients who:
- Want a standard async compounded GLP-1 program at mid-tier pricing
- Don't need a money-back guarantee or onboarding call
- Are comfortable with a newer brand without long-term Trustpilot history
It is not the right fit if:
- You want the absolute lowest price (GobyMeds at $99/mo will still beat Oak's $130/mo entry)
- You want broader medication options including branded and oral GLP-1 (SHED has the deepest menu)
- You want a wraparound care-team experience (SHED, Calibrate, or Mochi)
- Long-term brand reputation matters (Henry Meds, Hims, or Eden have more public history)
The Bottom Line
Oak is a budget-tier compounded GLP-1 telehealth program with one-price-all-dosages structure and an explicit no-subscription model. The pricing ($130/mo semaglutide, $199/mo tirzepatide) undercuts most established compounded providers, and the OAKNEW50 first-month discount makes the entry cost even lower.
What you trade for the price is public reputation: Oak is newer than Henry Meds, Hims, or Eden, with a thinner Trustpilot footprint and no money-back guarantee. If long-term brand history matters more than saving $20-$50/mo, the established names are still the safer pick. If price is the priority, Oak earns a real look.
Ready to learn more? Visit Oak to see the current program details.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you are experiencing a medical emergency, call 911.